Differences in cardiovascular mortality in smokers, past-smokers and non-smokers. Findings from the FRENA registry

European Journal of Internal Medicine

Volumn 20, Issue 5, 2009, Pages 522-526

  Surinach J M ^a   Alvarez L R ^b   Coll, R ^c   Carmona, J A ^d   Sanclemente, C ^e   Aguilar, E ^f   Monreal, M ^c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d HOSPITAL ALTO GUADALQUIVIR   (Spain)

^e HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^f Hospital de Alcañiz Alcañiz   (Spain)

Author keywords

Arterial disease; Outcome; Secondary prevention; Smoking

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; DISEASE REGISTRY; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT; RISK FACTOR; SMOKING; SMOKING HABIT;

AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; REGISTRIES; RISK FACTORS; SMOKING; SMOKING CESSATION; SPAIN;

EID: 68949207059     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.05.007     Document Type: Article

References (33)

1. Howard G., Wagenknecht L.E., Burke G.L., Diez-Roux A., Evans G.W., McGovern P., et al. Cigarette smoking and progression of atherosclerosis. The Athersoclerosis Risk in Communities (ARC) Study. JAMA 279 (1998) 119-124
2. Hasdai D., Garratt K.N., Grill D.E., Lerman A., and Holmes D.R. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med 336 (1997) 755-761
3. Ambrose J.A., and Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease. J Am Coll Cardiol 43 (2004) 1731-1737
4. Willigendael E.M., Teijink J.A.W., Bartelink M.L., Kuiken B.W., Boiten J., Moll F.L., et al. Influence of smoking on incidence and prevalence of peripheral arterial disease. J Vasc Surg 40 (2004) 1158-1165
5. Ezzati M., Henley S.J., Thun M.J., and Lopez A.D. Role of smoking in global and regional cardiovascular mortality. Circulation 112 (2005) 489-497
6. Yanbaeva D.G., Dentener M.A., Creutzberg E.C., Wesseling G., and Wouters E.F.M. Systemic effects of smoking. Chest 131 (2007) 1557-1566
7. Jha P., Jacob B., Gajalakshmi V., Gupta P., Dhingra N., Kumar R., et al. A nationally representative case-control study of smoking and death in India. N Engl J Med 358 (2008) 1137-1147
8. Rea T.D., Heckbert S.R., Kaplan R.C., Smith N.L., Lemaitre R.N., and Psaty B.M. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 137 (2002) 494-500
9. Bak S., Sindrup S.H., Alsley T., Kristensen O., Christensen K., and Gaist D. Cessation of smoking after first-ever stroke. A follow-up study. Stroke 33 (2002) 2263-2269
10. Taylor D.H., Hasselblad V., Henley S.J., Thun M.J., and Sloan F.A. Benefits of smoking cessation for longevity. Am J Public Health 92 (2002) 990-996
11. Doll R., Peto R., Boreham J., and Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 328 (2004) 1519
12. Anthonisen N.R., Skeans M.A., Wise R.A., Manfreda J., Kanner R.E., Connett J.E., et al. The effects of a smoking cessation intervention on 14.5-year mortality. Ann Intern Med 142 (2005) 233-239
13. Antman EM, Armstrong PW, Bates ER, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC Jr; 2004 Writing Committee Members, Anbe DT, Kushner FG, Ornato JP, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 Writing Committee. Circulation 2008; 117: 296-329.
14. Barbash G.I., Reiner J., White H.D., Wilcox R.G., Armstrong P.W., Sadowski Z., et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. JACC 26 (1995) 1222-1229
15. Gottlieb S., Boyko V., Zahger D., Balkin J., Hod H., Pelled B., et al. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli thrombolytic national survey). JACC 28 (1996) 1506-1513
16. Andrikopoulos G.K., Richter D.J., Dilaveris P.E., Pipilis A., Zaharoulis A., Gialafos J.E., et al. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction. The "smoker's paradox in a countrywide study. Eur Heart J 22 (2001) 776-784
17. Cohen D.J., Doucet M., Cutlip D.E., Ho K.K.L., Popma J.J., and Kuntz R.E. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention. Another smoker's paradox?. Circulation 104 (2001) 773-778
18. Ruiz-Bailen M., Aguayo de Hoyos E., Reina-Toral A., Torres-Ruiz M., Álvarez-Bueno M., Gómez Jiménez F.J., et al. Paradoxical effect of smoking in the Spanish population with acute myocardial infarction or unstable angina. Results of the ARIAM Register. Chest 125 (2004) 831-840
19. Kunz F., Pechlaner C., Hörtnagl H., and Pfister R. The smoker's paradox and the real risk of smoking. Eur J Epidemiol 20 (2005) 161-167
20. Weisz G., Cox D.A., Garcia E., Tcheng J.E., Griffin J.J., Guagliumi G., et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction-The smoker's paradox revisited. Am Heart J 150 (2005) 358-364
21. Katayama T., Iwasaki Y., Sakoda N., and Yoshioka M. The etiology of "smoker's paradox" in acute myocardial infarction with special emphasis on the association with inflammation. In Heart J 49 (2008) 13-24
22. Monreal M., Alvarez L., Vilaseca B., Coll R., Suárez C., Toril J., et al. Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA). Eur J Intern Med 19 (2008) 192-197
23. Lopez-Jimenez L., Camafort M., Tiberio G., Carmona J.A., Guijarro C., Martínez-Peñalver F., et al. Secondary prevention of arterial disease in very elderly people: results from a prospective registry (FRENA). Angiology 59 4 (2008) 427-434
24. Dormandy J.A., and Rutherford B. Management of peripheral arterial disease (PAD) TASC Working Group. Trans Atlantic Inter-Society Consensus (TASC). J Vasc Surg 31 (2000) S1-S96
25. Godtfredsen N.S., Prescott E., Osler M., and Vestbo J. Predictors of smoking reduction and cessation in a cohort of Danish moderate and heavy smokers. Prev Med 33 (2001) 46-52
26. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
27. Gomez M.A., Karagounis L.A., Allen A., and Anderson J.L. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. Am J Cardiol 72 (1993) 373-378
28. Critchley J.A., and Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 290 (2003) 86-97
29. Adams R.J., Albers G., Alberts M.J., Benavente O., Furie K., Goldstein L.B., et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 39 (2008) 1647-1652
30. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25 (2008) 457-507
31. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G.R., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg (2007) S5A-S67A
32. Patrick D.L., Cheadle A., Thrompson D.C., Diehr P., Koepsell T., and Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health (1994) 1086-1093
33. Attebring M.F., Herlitz J., Berndt A.K., Karlsson T., and Hjalmarson A. Are patients truthful about their smoking habits? A validation of self-report about smoking cessation with biochemical markers of smoking activity amongst patients with ischaemic heart disease. J Intern Med 249 (2001) 145-151